EBITDA Margin (Annual)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Guardant Health, Inc. (GH) had EBITDA Margin of -41.08% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$982.02M
Net Income	$-416.28M
Cost of Goods Sold	$349.01M
Gross Profit	$633.01M
Operating Expenses	$1.42B
Operating Income	$-437.25M
Non-Operating Income/Expense	$19.71M
Pre-Tax Income	$-417.54M
Normalized Pre-Tax Income	$-417.54M
Income after Taxes	$-416.28M
Income from Continuous Operations	$-416.28M
Consolidated Net Income/Loss	$-416.28M
Normalized Income after Taxes	$-416.28M
EBIT	$-437.25M
EBITDA	$-403.39M
Weighted-Average Shares Outstanding (Basic)	125.37M
Weighted-Average Shares Outstanding (Diluted)	125.37M
Earnings per Share (EPS) (Basic)	$-3.32
Earnings per Share (EPS) (Diluted)	$-3.32
Balance Sheet Financials
Current Assets	$1.47B
Property, Plant, and Equipment	$145.91M
Long-Term Assets	$547.61M
Total Assets	$2.01B
Current Liabilities	$302.73M
Long-Term Debt	$1.50B
Long-Term Liabilities	$1.81B
Total Liabilities	$2.11B
Common Equity	$-99.31M
Tangible Shareholders Equity	$-202.49M
Shareholders Equity	$-99.31M
Common Shares Outstanding	130.63M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-184.76M
Cash Flow from Investing Activities	$-627.20M
Cash Flow from Financial Activities	$671.13M
Beginning Cash	$629.75M
End Cash	$489.42M
Increase/Decrease in Cash	$-140.34M
Stock-Based Compensation	$166.22M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.84
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.07
Debt to Equity Ratio	-15.14
Gross Margin	64.46%
Operating Margin	-44.53%
EBIT Margin	-44.53%
EBITDA Margin	-41.08%
Pre-Tax Profit Margin	-42.52%
Profit Margin	-42.39%
Free Cash Flow	$-233.07M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.49
Inventory Turnover	4.06
Receiveable Turnover	7.12
Days Sales in Receivables	51.24
Return on Equity	419.18%
Return on Tangible Equity	205.58%
Return on Assets	-20.67%
Return on Investments	-29.63%
Book Value Per Share	$-0.76
Free Cash Flow per Share	$-1.86
Operating Cash Flow per Share	$-1.47

Data from Zacks Investment Research, Inc.